RT-qPCR analysis from tumor RNA samples reflected the efficient downregulation of DYRK3 by doxycycline treatment (Figure 3D), thus confirming a critical and previously unrecognized role for this kinase in NB cell proliferation and in vivo tumor growth. This evidence concerns the gene DYRK3 and neuroblastoma.